Additionally, the lack of federal regulatory oversight around compounded peptide products which are not subject to the same strict manufacturing and purity standards as FDA-approved drugs allows for safety concerns, such as potential risks of sterility issues, inaccurate dosages, unknown side effects, and product contamination
Stomach emptying and fullness Some therapies slow stomach emptying
Comparison of bodyweight (A) and abdominal visceral fat (B) from baseline to week 68 for semaglutide 2.4 mg, semaglutide 1.7 mg, and placebo in Janpanese and Korean people with obesity
One of the common questions that Im getting these days is: Would we see the same result with other GLP-1s or with other biologics
People can respond differently based on their diet, lifestyle, and health, and finding the best way to manage these symptoms may take some time